US NEWS FEEDS
Vivitrol, which costs $1,000 an injection, shows some hope in treating addicts but its aggressive marketing has come under fire, and the drug is not without risks.
A multinational drug company has quietly carved out a lucrative, publicly subsidized market for an expensive—and risky—medicine that the company promises can help rescue Illinois from its opioid crisis.…
News & Politics, Chicago Reader
READ MORE >
Officials hope much-hyped drug can slow state's opioid crisis, but is it worth the costs?